Bill > A07953

This bill amends several sections of New York's insurance and social services laws to mandate that screenings for elevated lead levels be covered by health insurance policies without annual deductibles or coinsurance. Specifically, the bill requires that health insurance policies, including individual, group, and commercial plans, as well as Medicaid, provide coverage for lead level screenings at no additional cost to the patient. The bill references the definition of "elevated lead levels" as defined in subdivision six of section thirteen hundred seventy of the public health law, which likely specifies the specific blood lead level that is considered elevated and requires medical attention. By removing financial barriers to lead screening, the bill aims to encourage more comprehensive lead testing, which is particularly important for children who are most vulnerable to the harmful effects of lead exposure. The legislation will take effect immediately upon passage, ensuring quick implementation of these coverage requirements across New York's health insurance systems.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A7953